3D Ultrasound Market Regional Analysis

North America accounted for the largest market share and is expected to maintain its dominance over the forecast period. North America dominance is contributed by factors such as increasing number of product launches and favourable reimbursement. In the field of 3D imaging, the region is also witnessing continuous technological advancement. Moreover, increasing research and development expenses and a rising patient pool are also boosting the market growth. According to the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 30 million persons in the U.S. Ultrasound-guided injections play an essential role in treating osteoarthritis and are more effective than oral medicines. USFDA's Center for Devices and Radiological Health (CDRH), is working towards reducing unnecessary radiation exposure from medical imaging. It has started an initiative in response to safety concerns raised in FDA's Safety Investigation of CT Brain Perfusion Scans and rising exposure to ionizing radiation from medical imaging that was highlighted in National Council on Radiation Protection and Measurements. Furthermore, demand for 3D ultrasound is expected to increase due to its non-ionizing radiation and non-invasive procedure, which is expected to drive market revenue growth in this region.

In Asia Pacific, the market for 3D ultrasound is likely to witness the fastest growth rate during the forecast period. The growth is contributed by rising patient pool and a rising preference for minimally invasive surgeries. The use of ultrasound outside of traditional core applications; cardiology, radiology, and women's health remained underuse in the developing market. Factors that are contributing to market growth are Increasing government initiatives to promote cheaper manufacturing of medical devices and rapid technological advancements made in the field of 3D imaging.